Sentence examples for treatment of intermediate from inspiring English sources
To compare interferon (IFN) beta with methotrexate (MTX) in the treatment of intermediate uveitis with macular edema.
To evaluate whether cost, insurance prior authorization, pregnancy considerations, and subspecialty practice lead to changes in therapeutic decisions among uveitis and retina specialists in the treatment of intermediate and posterior uveitis.
Recently performed clinical trials reported the efficacy of DEBs in the treatment of intermediate stage HCC [130, 132, 133, 134, 135], with good objective response (complete plus partial response) rates ranging 60% 85.5% (according to the EASL response criteria).
Subsequent treatment of intermediate 7, with tert-butyl hydrazine hydrochloride (8) in the presence of triethylamine in trichloromethane at ambient temperature afforded 3-bromo-N′- tert-butyl -1- 3-chloropyridin-2-yl -1H-pyrazole-5-carbohydrazide (9) in 80% yield.
The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers.
Second, the most favored agent for the treatment of intermediate and posterior/panuveitis was mycophenolate mofetil, a preference supported at least in part by high success rates with this agent in the Systemic Immunosuppressive Therapy for Eye (SITE Diseases Cohort Studyy [14, 15, 26].
If enacted, these proposed amendments would align the treatment of "intermediate-form" mergers with "long-form" mergers with respect to the availability of appraisal rights.
Vaginal brachytherapy (VBT) using a cylinder applicator is a standard treatment of intermediate- and high-risk endometrial cancer.
The recurrence in treatment of intermediate-risk patients is modest; CCRT and adjuvant chemotherapy may be the best standard for them.
These drugs are now proposed as an alternative to the usual combination of LMWH overlapped and followed by vitamin K antagonist(s) (VKA) for the treatment of intermediate-risk or low-risk PE [6].
Subsequent treatment of intermediates 2 with different aldehydes in ethanol at room temperature afforded the desired compounds (3a to 3k).
